Myotonic Dystrophy Type 1: Disease Development & Symptom Management - 2023 MDF Annual Conference

Myotonic Dystrophy Type 1: Disease Development & Symptom Management - 2023 MDF Annual Conference
Share:

Download MP3


Similar Tracks

Disease Severity and Progression in Myotonic Dystrophy Type 2 Myotonic Dystrophy Foundation
How Common is Myotonic Dystrophy in the United States? Findings from the Recent Prevalence Study Myotonic Dystrophy Foundation
Welcome & State of the Foundation - 2023 MDF Annual Conference Myotonic Dystrophy Foundation
Ask-the-Expert: Gastrointestinal (GI) Issues & Myotonic Dystrophy Myotonic Dystrophy Foundation
Think Fast, Talk Smart: Communication Techniques Stanford Graduate School of Business
DM2: Disease Development, Symptoms, & Management - 2021 MDF Annual Conference Myotonic Dystrophy Foundation
Paramyotonia Congenita - An Expert Discussion | PPA SUMMIT 2021 Supercut #4 Periodic Paralysis Association
Dr. John Day - Myotonic Dystrophy Research: What's Next? Stanford Neuromuscular Program
Ask-the-Expert: Reproductive Health & Myotonic Dystrophy Myotonic Dystrophy Foundation
How to Approach and Treat Pancreatic Cancer OncBrothers: Practice-Changing Cancer Discussions
Congenital Syphilis Prevention Arkansas Perinatal Quality Collaborative
How to Speak MIT OpenCourseWare
Identifying, diagnosing and treating patients with later-onset SMA Touch Medical Media
Welcome & Research Update with Dr. Cody - World C18 Day 2024 Jannine Cody
How To Speak English Continuously, Without Hesitating Or Translating EnglishAnyone
MGR 12 12 19 CALCIPHYLAXIS Rochester Regional Health - Medical Grand Rounds
Myotonic Dystrophy: An Overview and Update Myotonic Dystrophy Foundation
Efficacy of AMO-02 (tideglusib) in Myotonic Dystrophy Type 1 (DM1) CheckRare
Marty Lobdell - Study Less Study Smart Pierce College District WA
Medication Selection for the Treatment of Early Psychosis: Using a Person Centered Approach NAMI NH